Furthermore, levels of HA signaling pathway mediators and regulators of HA synthesis such as RHAMM, CD44, hyaluronidases, and hyaluronan synthases have shown prognostic potential in lung cancer warranting further validation [19–22]. The gene discussed is CD44; the disease is lung carcinoma.